205 related articles for article (PubMed ID: 7586800)
1. Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone.
Rao VH; Bridge JA; Neff JR; Schaefer GB; Buehler BA; Vishwanatha JK; Pollock RE; Nicolson GL; Yamamoto M; Gokaslam ZL
Clin Exp Metastasis; 1995 Nov; 13(6):420-6. PubMed ID: 7586800
[TBL] [Abstract][Full Text] [Related]
2. Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone.
Rao VH; Singh RK; Bridge JA; Neff JR; Schaefer GB; Delimont DC; Dunn CM; Sanger WG; Buehler BA; Sawaya R; Nicolson GL; Rao JS
Clin Exp Metastasis; 1997 Jul; 15(4):400-9. PubMed ID: 9219728
[TBL] [Abstract][Full Text] [Related]
3. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis.
Zeng ZS; Cohen AM; Guillem JG
Carcinogenesis; 1999 May; 20(5):749-55. PubMed ID: 10334190
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases.
Quesada AR; Barbacid MM; Mira E; Fernández-Resa P; Márquez G; Aracil M
Clin Exp Metastasis; 1997 Jan; 15(1):26-32. PubMed ID: 9009103
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints.
Clegg PD; Burke RM; Coughlan AR; Riggs CM; Carter SD
Equine Vet J; 1997 Sep; 29(5):335-42. PubMed ID: 9306058
[TBL] [Abstract][Full Text] [Related]
6. Identification and partial characterization of three calcium- and zinc-independent gelatinases constitutively present in human circulation.
Makowski GS; Ramsby ML
Biochem Mol Biol Int; 1998 Dec; 46(5):1043-53. PubMed ID: 9861458
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.
Ueda Y; Imai K; Tsuchiya H; Fujimoto N; Nakanishi I; Katsuda S; Seiki M; Okada Y
Am J Pathol; 1996 Feb; 148(2):611-22. PubMed ID: 8579123
[TBL] [Abstract][Full Text] [Related]
8. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro.
Pickett KL; Harber GJ; DeCarlo AA; Louis P; Shaneyfelt S; Windsor LJ; Bodden MK
J Dent Res; 1999 Jul; 78(7):1354-61. PubMed ID: 10403463
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of a high molecular weight type IV collagenase isolated from human carcinoma tissue.
Tsuda TT; Kodama A; Yamamura M; Matsuzaki S; Tsuda M
FEBS Lett; 1993 Mar; 319(1-2):35-9. PubMed ID: 8384126
[TBL] [Abstract][Full Text] [Related]
10. [Matrix metalloproteinase-2 concentrations in squamous cell carcinoma of the head and neck and its clinical significance].
Kawata R; Shinomiya T; Yasuda N; Takenaka H; Murakami Y
Nihon Jibiinkoka Gakkai Kaiho; 1996 Feb; 99(2):299-305. PubMed ID: 8851335
[TBL] [Abstract][Full Text] [Related]
11. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.
Nakagawa T; Kubota T; Kabuto M; Fujimoto N; Okada Y
J Neurooncol; 1996 Apr; 28(1):13-24. PubMed ID: 8740587
[TBL] [Abstract][Full Text] [Related]
12. Collagenase-1, stromelysin-1 and 92 kDa gelatinase are associated with tumor necrosis factor-alpha induced morphological change of human endothelial cells in vitro.
Nelimarkka LO; Nikkari ST; Ravanti LS; Kähäri VM; Järveläinen HT
Matrix Biol; 1998 Aug; 17(4):293-304. PubMed ID: 9749945
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status.
Mäkelä M; Salo T; Uitto VJ; Larjava H
J Dent Res; 1994 Aug; 73(8):1397-406. PubMed ID: 8083435
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer.
Zervos EE; Shafii AE; Rosemurgy AS
J Surg Res; 1999 Jan; 81(1):65-8. PubMed ID: 9889060
[TBL] [Abstract][Full Text] [Related]
15. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of gelatinases/type IV collagenases in jaw cysts.
Teronen O; Salo T; Konttinen YT; Rifkin B; Vernillo A; Ramamurthy NS; Kjeldsen L; Borregaard N; Hietanen J; Sorsa T
J Oral Pathol Med; 1995 Feb; 24(2):78-84. PubMed ID: 7745546
[TBL] [Abstract][Full Text] [Related]
17. Expression and activity of MMPS and their regulators in ovarian cancer.
Naylor MS; Stamp GW; Davies BD; Balkwill FR
Int J Cancer; 1994 Jul; 58(1):50-6. PubMed ID: 8014015
[TBL] [Abstract][Full Text] [Related]
18. Alendronate blocks metalloproteinase secretion and bone collagen I release by PC-3 ML cells in SCID mice.
Stearns ME; Wang M
Clin Exp Metastasis; 1998 Nov; 16(8):693-702. PubMed ID: 10211982
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours.
Rooprai HK; Van Meter T; Rucklidge GJ; Hudson L; Everall IP; Pilkington GJ
Int J Oncol; 1998 Dec; 13(6):1153-7. PubMed ID: 9824624
[TBL] [Abstract][Full Text] [Related]
20. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
Terada T; Okada Y; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]